BATURA trial results showed that as-needed use of an ICS-SABA combination may help control symptoms and mitigate exacerbation risk in often overlooked patients with mild asthma.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles


